• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

FDA committee recommends approval of alefacept (Amevive) for treatmentof psoriasis

Silver Spring, Md. - The FDA Dermatologic and OphthalmicAdvisory Committee on May 23 strongly recommended approval of alefacept,a systemic drug for the treatment of chronic plaque psoriasis.

Related Videos
3 experts are featured in this series.
Related Content
Platelet-Rich Plasma in Hair Transplantation Shows Success in Patients with Androgenetic Alopecia
November 21st 2024

Platelet-Rich Plasma in Hair Transplantation Shows Success in Patients with Androgenetic Alopecia

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
August 2nd 2024

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

Advancing Treatment of Solar Lentigines Through the Vasculature Salvage Laser Surgery System
November 21st 2024

Advancing Treatment of Solar Lentigines Through the Vasculature Salvage Laser Surgery System

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
July 1st 2024

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

AI Chatbots Can Provide Support to Patients with Hidradenitis Suppurativa
November 20th 2024

AI Chatbots Can Provide Support to Patients with Hidradenitis Suppurativa

Study Reveals 90% Acne Severity Reduction with TF-LDM
November 20th 2024

Study Reveals 90% Acne Severity Reduction with TF-LDM

© 2024 MJH Life Sciences

All rights reserved.